Current calls, week 38, 2022
Tips from Grants Office regarding current calls
Swedish and Nordic calls
Research Institute Doctoral Student 2022 – Swedish Foundation for Strategic Research (SSF)
The Swedish Foundation for Strategic Research (SSF) is allocating SEK 20 million in a programme for research institute doctoral students. Each grant in the programme provides funding for research and postgraduate studies for a doctoral student who is employed at a Swedish research institute, in collaboration with academia. The grant runs for four to five years and shall result in a doctorate exam (PhD). SSF expects to fund eight projects at SEK 2.5 million each (including indirect costs) in this call for proposals.
Closing date: November 30, 2022
Project grant: Welfare among children and young people in the post-pandemic Nordics – NordForsk
The overall objective of the call is to support and accelerate cutting edge Nordic research with high potential for renewal and impact on the welfare among children and young people in the post-pandemic Nordics. The call has an emphasis on education, wellbeing, mental health, and living conditions of children and young people. The objective of the call is also to support research on the mitigation of the effects of the pandemic and the restrictions on the welfare of children and young people.
Research projects must include partners from research performing organisations in at least three Nordic countries. The budget is NOK 77 million. Seven grants are available, each worth up to NOK 11 million for three to four years.
Closing date: December 8, 2022
KI travel award for collaboration with the University of Tokyo 2022/2023
To facilitate new and existing contacts between doctoral student and post docs as well as increase research collaboration with the University of Tokyo, the Internationalisation Advisory Council is pleased to announce the availability of limited competitive funds for a lab visit at the University of Tokyo during 2022/2023.
The proposed travel should take place between December 2022 and 31st of December 2023.
Closing date: 17th of October 2022
Wera Ekströms stiftelse för pediatrisk forskning
Fonden utdelar anslag inom det pediatriska forskningsområdet i första hand med inriktning på de sjukdomstillstånd som drabbar ämnesomsättningen.
Anslaget avses användas till forskarstipendier under 3-12 månader.
Closing date: November 1, 2022
Joint seed funding available for research collaboration with University College London (UCL)
The Cities Partnerships Programme Stockholm, comprising UCL and the Stockholm Trio of Karolinska Institutet, KTH Royal Institute of Technology & Stockholm University (KI, KTH & SU), announces a new round of joint research funding to continue to support collaborative research projects and to build on the existing partnerships between the three institutions. The aim of the fund is to catalyze new collaborations and in the longer term to build international teams who are well positioned to apply for external research funding.
KI researchers that partner with UCL in an application are eligible to apply for co-funding from KI to fund their contribution to the project, subject to internal prioritisation.
Closing date: 31 October 2021 (23:59 Swedish time).
Please find the application form on UCL’s website. If you have any questions, please contact Lotta Lundqvist, international relations office at email@example.com
Regular grant programme, World Cancer Research Fund International, INT
This funding opportunity supports research on the link between diet, nutrition, body composition, physical activity, and cancer prevention and survival.
The following research areas are of particular relevance for the WCRF International Grant Programme:
- Biological mechanisms by which diet, nutrition and physical activity affect cancer processes
- The impact of diet, nutrition and physical activity throughout the life course on cancer risk
- The impact of diet, nutrition and physical activity on outcomes in cancer survivors
- Globally representative research on relevant exposures and cancer
Two types of grants are available:
Investigator initiated grants
- Up to £350,000 (no more than £100,000 for any 1 year). Duration: max. 4 years.
- Lead applicants must hold a research position at the host institution for the duration of the project.
- Collaboration with other teams are encouraged, therefore it is important to have at least one coapplicant.
- Instructions for completing the application forms Investigator Initiated Grant and Grant guidelines
Pilot and feasibility grants
- Up to £60,000 each over two years.
- Lead applicants must hold a research position at the host institution for the duration of the project.
- More info
- Outline of applications: 17:00 GMT on 7 November 2022
- Full applications: 17:00 GMT on 15 March 2023
International grants, Biocodex Microbiota Foundation, FR
This funding opportunity supports clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, projects will explore the functional role of antibiotic resistance genes within the gut microbiome, with a focus on anaerobic microorganisms that are difficult to assess in routine clinical microbiology.
Eligibility: Physicians, PhDs and doctors of pharmacy working in subject areas, such as gastroenterology, paediatrics, microbiology, infectious diseases and internal medicine and based anywhere in the world, may apply.
Budget: €200,000 over one to three years. 10% INDI coverage.
Closing date: 30 November, 2022
Postdoctoral research fellowship exchange programme, European Committee for Treatment and Research in Multiple Sclerosis, CH
ECTRIMS offers a postdoctoral research fellowship programme for young neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to multiple sclerosis. The goal of the programme is to maximise the exchange of information and to help grow the pool of well-trained research scientists focused on problems in MS.
Eligibility: Scientists and physicians who are under the age of 40 and hold or are candidates for an MD, PhD, ScD or equivalent professional degree, may apply.
Budget: €55,000 per year for up to two years and include salary and travel costs.
Closing date: 1 December, 2022
EFSD new targets for diabetes or obesity-related metabolic diseases, European Association for the Study of Diabetes, EUR
The European Foundation for the Study of Diabetes, in partnership with Merck, Sharpe & Dome, invites applications for its call on new targets for diabetes or obesity-related metabolic diseases. This aims to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes or obesity-related metabolic diseases.
Eligibility The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be conducted at their place of work.
Budget: Up to €100,000 each for projects lasting one year or longer.
Closing date: 1 December, 2022
Federal Funding agencies
Notice of Special Interest (NOSI): Small Research Grants for Innovations in Healthy Longevity Research: NIH
This Notice of Special Interest (NOSI) invites applications for small research grants that align with the goals of the National Academy of Medicine's Healthy Longevity Grand Challenge. NIA is interested in projects that reflect its mission to support research on aging, the aging process, and diseases and conditions associated with growing older, including AD/ADRD. Applications that reflect NIA’s programmatic interests in genetic, biological, clinical, epidemiological, neuroscience, behavioral, social, and economic research on aging as they relate to healthy longevity are encouraged. Projects should inform the overall mission of the Healthy Longevity Global Grand Challenge and include bold, new, and innovative ideas to extend health and function as people age.
Deadline: February 16, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): NOT-AG-22-030
Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed): NIH
This funding opportunity announcement (FOA) aims to support complementary research programs that adopt innovative scalable technologies to inventory, register and profile cellular ensembles and/or cell-types that produce and/or respond to opioids in the rodent brain, or that are engaged during different stages of opioid use (acute, chronic, withdrawal, abstinence, relapse). Emphasis is on approaches capable of integrating data generated through molecular profiling, at single-cell resolution, with other data modalities, such as cellular activity, connectivity and/or spatial localization, collected from the same cells or cell-types. The overarching goal of the FOA is to deliver multimodal reference datasets that will constitute useful resources to the research community and will provide a foundational biological framework to advance the understanding and treatment of opioid-associated states.
Deadline: February 02, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-DA-23-035
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional): NIH
The purpose of this Funding Opportunity Announcement (FOA) is to accelerate research to better understand the emergence, trajectory, and outcome of schizophrenia and related psychotic disorders in mid- to late-life. For the purposes of this FOA, schizophrenia and related psychotic disorders include the nonaffective psychotic disorders (e.g., schizophrenia spectrum disorders, delusional and other nonorganic psychotic disorders) but also bipolar disorder with psychosis. Since on average, persons with schizophrenia and related psychotic disorders have a shorter lifespan, the mid- to late-life life period is defined as 35 years old and above. Research that identifies mechanisms underlying the risk, emergence, and outcome of schizophrenia and related psychotic disorders during mid- to late-life is of special interest. Mechanisms include, but are not limited to biological, behavioral, psychosocial, and environmental. Research to identify mechanisms for targets within an experimental therapeutics approach (e.g., the NIH Stage Model) leading to intervention development or that identify ways to modify existing healthcare and community-based services to better support individuals with schizophrenia and related psychotic disorders in mid- to late-life is of special interest.
Deadline: February 22, 2023. Applications are due by 5:00 PM local time of applicant organization.
Funding Opportunity Announcement (FOA): RFA-MH-22-270
Research grants, Parkinson’s Foundation, US
The Parkinson’s Foundation are offering a number of funding opportunities in the field of Parkinson’s research. The following awards are available:
Postdoctoral Fellowships for Basic Scientists. Two-year fellowships for young scientists fresh from their PhD training.
Eligibility: Applicants must be within five years of receiving their PhD at the start of the award and must name an individual who will serve as their research supervisor. If awarded, a Postdoctoral Fellow must commit 90 percent of his or her effort to the Parkinson's Foundation-funded project.
Budget: This program grants $124,000 over two years. This consists of $57,000 annually (to be used as salary) as well as a $5,000 annual research allowance to be used at the Fellow's discretion, with sponsor/mentor approval, to pay for items such as books, training courses, travel costs (up to $2,000), or a computer. There is no provision for the deduction of postdoctoral taxes, institutional overhead or fees.
Postdoctoral Fellowships for Clinical Neurologists. Two-year fellowships for young scientists fresh from their neurology residencies.
Eligibility: Applicants seeking a Postdoctoral Fellowship for Neurologists must possess an M.D. or equivalent and be within three years of having completed a residency in neurology at the time the award starts. Applicants may not have their own lab and must name an individual who will serve as his or her mentor and supervisor of their research. if awarded, we require a Clinical Fellow to commit 80 percent of his or her effort to the Parkinson's Foundation-funded project.
Budget: This program grants $140,000 over two years. This consists of $65,000 annually (to be used as salary) as well as a $5,000 annual research allowance to be used at the Fellow's discretion, with sponsor/mentor approval, to pay for items such as books, training courses, travel costs (up to $2,000), or a computer. There is no provision for the deduction of postdoctoral taxes, institutional overhead or fees.
Launch Award. Four-year, two-stage award for outstanding postdoctoral researchers that will enable them to complete needed mentored training and transition promptly to independent research careers in PD.
Eligibility: Applicant must possess a PhD, MD, or equivalent degree and be within 18 months to 6 years of completing that degree or clinical training at the time of application, including resubmission. Applicant must currently be in a postdoctoral or other mentored position and must name and provide a letter of support from an established investigator who will serve as the mentor and supervisor.
Budget: A total of $400,000 for up to 4 years, split over two stages.
Deadlines: LOI - 1st November 2022. Full application – 24th February, 2023.
Impact Award. Impact Awards are designed for researchers both established and new to the field of PD. Projects should be "outside the box" with the goal of bringing new light to the biology of Parkinson's, a new approach to Parkinson’s research, or testing a truly novel therapeutic idea.
Eligibility: Only independent investigators are welcome to apply. We will consider applications from Instructors who can demonstrate that they will begin a tenure-track position (as shown by a support letter from their department chair). All applications must demonstrate a significant research focus and impact on PD.
Budget: Awards are up to a maximum of $150,000 for 12-18 months. Up to 10% ($15,000) of the total award may be used towards indirect costs. Salary support is permitted for no more than 40% of the principal investigator’s salary and capped at $50,000.
Deadline: LOI – 4th November 2022. Full application – 27th February, 2023.
Competitive grant program, Growth Hormone Research, Pfizer, US
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Research projects that will be considered for Pfizer support will advance the medical knowledge of short stature. Projects submitted may include:
- Morbidities in growth disorders
- Strategies to evaluate and treat growth disorders including Quality of Life and Patient Reported Outcomes
- Comparative pathophysiology of daily vs long-acting growth hormone
- Evaluation of adherence of daily and long-acting growth hormone treatment
- Novel strategies to address current unmet medical needs in short stature management which could be addressed with long-acting growth hormone treatment
- Comparison of clinical effects of daily vs long-acting growth hormone
- Projects may include basic, translational or clinical research
Eligibility: The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
Budget: Individual projects requesting up to $150,000 will be considered. Pfizer anticipates awarding a minimum of 2 projects. Pfizer has set a maximum rate of 28% for indirect costs.
Deadline: Full application – 13th February, 2023.
Integrative programme, Gateway for Cancer Research, US
The Gateway for Cancer Research invites letters of intent for its integrative programme. This supports integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment. This also aims to increase quality of life, especially post-treatment.
Budget: Grants are typically two to five years in duration with award amounts from USD 200,000 to USD 1.5 million. Indirect costs are not covered.
Deadline: LOI – 1st November, 2022. Full application – by invitation, 4-5 weeks after LOI.